Geode Capital Management
PRVL

Geode Capital Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Geode Capital Management’s Portfolio PRVL Stock Details PRVL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
2020
Q4 		$3.63M Sell
2020
Q3 		$1.74M Buy
2020
Q2 		$2.44M Buy
2020
Q1 		$1.89M Buy
2019
Q4 		$1.56M Buy
2019
Q3 		$1M Buy